임상

HOME > 연구실적 > 임상 > 논문
 
작성일 : 16-03-14 01:13
논문번호 116
논문제목(영문) Clinical Comparison of Drug-Eluting Stents and Bare Metal Stents in Large Coronary Arteries.
국내외구분 국내 SCI여부 SCI
연구책임자역할 공저자
주저자명 Kim WJ
교신저자명 Cho JH
공동저자명 Kim WJ, Cho JH, Jung JH, Lee MK, Yoon JS, Ahn YS, Hwang YJ, Jung HM, Kim SH, Kim JY, Jeong MH;
게제년월일 2011-04-27
ISSN 1226-3303
Impact Factor 1.426
학술지명 Korean Journal of Internal Medicine
서지사항 0집 / 80권 / 6호,   페이지(664 - 671)
요약초록문
(Abstract) 입력		 Abstract: Background/Aims: Drug-eluting stents (DES) are superior to bare metal stents (BMS) in reducing restenosis rates across a wide range of patients and lesion subsets.This study compared the clinical outcomes of DES versus BMS in patients with large coronary arteries (≥ 3.5 mm).
Methods: The study compared 134 patients (59.9 ± 10.6 years, 90 men, 44 women) who underwent single vessel angioplasty with DESimplantation in large vessels with 115 patients (60.3 ± 8.9 years, 82 men, 33 women) who received BMS. The clinical outcomes at 12 months were compared between groups. The study end points were major adverse cardiac events (MACE), including cardiac death, nonfatal myocardial infarction, and the need for target vessel and target lesion revascularization.
Results: The baseline clinical coronary angiography and procedural characteristics were similar in both groups. The duration of dual antiplatelet therapy was longer in the DES group than in the BMS group (240 ± 2.7 vs. 348 ± 1.7 days, p = 0.042). During the 12-month clinical follow-up, MACE were observed in 13 patients (11.3%) with BMS and 12 patients (9.0%) with DES (p = 0.486).
Conclusions: For coronary stents implanted in large coronary arteries, DES seems to be more favorable, although no significant differences were observed in the clinical outcomes between DES and BMS during a 1-year clinical follow-up.
파일  C116.+Korean+J+Med+2011;80(6)664-671..pdf (319.0K) DATE : 2021-05-25 15:21:04